ABSTRACT Background: Circulating 25-hydroxyvitamin D [25(OH)D] and parathyroid hormone (PTH) concentrations have been shown to be associated with insulin sensitivity; however, adiposity may confound this relation. Furthermore, African Americans (AAs) have lower insulin sensitivity and 25(OH)D concentrations than do European Americans (EAs); whether these differences are associated in a cause-and-effect manner has not been determined. Objectives: The objectives of this study were to examine the relation of 25(OH)D and PTH concentrations with whole-body insulin sensitivity and to determine whether lower 25(OH)D concentrations in AAs compared with EAs contribute to the lower insulin sensitivity of AAs relative to that of EAs. Design: This was a cross-sectional study of 25 AA and 25 EA women. We determined the whole-body insulin sensitivity index (S I ) with an intravenous glucose tolerance test and minimal modeling. Percentage body fat was determined with dual-energy X-ray absorptiometry, and intraabdominal adipose tissue (IAAT) was determined with computed tomography. Conclusions: 25(OH)D and PTH concentrations were independently associated with whole-body insulin sensitivity in a cohort of healthy women, which suggested that these variables may influence insulin sensitivity through independent mechanisms. Furthermore, ethnic differences in 25(OH)D concentrations may contribute to ethnic differences in insulin sensitivity.
INTRODUCTION
Vitamin D may play a role in maintaining insulin sensitivity (1) , the loss of which has been implicated in the progression of type 2 diabetes (2). Cross-sectionally, 25-hydroxyvitamin D [25(OH)D] concentrations are generally shown to be associated with insulin sensitivity (1, (3) (4) (5) (6) . However, because vitamin D may become sequestered in adipose tissue (7) and obesity is associated with vitamin D deficiency (8, 9) and insulin resistance (2) , adiposity may be a confounder of these relations (10) . Parathyroid hormone (PTH) concentrations are often elevated in vitamin Ddeficient states (11) and may further confound the relation between 25(OH)D concentrations and insulin sensitivity because PTH has also been shown to be positively associated with insulin sensitivity (12, 13) . Indexes of insulin sensitivity derived from fasting values of insulin and glucose, such as the homeostatic model assessment of insulin resistance (HOMA-IR), are commonly used to investigate the associations between 25(OH)D concentrations and insulin sensitivity (1) . These indexes tend to reflect more hepatic insulin resistance (14) as opposed to wholebody insulin sensitivity, which encompasses both hepatic and peripheral insulin sensitivity (15) . In addition, the accuracy of indexes such as HOMA-IR in estimating whole-body insulin sensitivity may vary by ethnicity and obesity status (16) . To our knowledge, no previous study has examined the relation between 25(OH)D concentrations and a direct measure of wholebody insulin sensitivity after adjusting for a robust measure of adiposity and PTH concentrations.
African Americans (AAs) have a disproportionately greater risk of insulin resistance and type 2 diabetes than do European Americans (EAs) (17) . The causes of ethnic differences in insulin sensitivity are not clear and have not been explained by differences in adiposity and body composition (17) . AAs also generally have lower serum 25(OH)D concentrations than EAs (9) . To our knowledge, it has not been examined whether lower serum 25(OH)D concentrations in AAs relative to those in EAs contribute to ethnic differences in insulin sensitivity.
The overall objective of this study was to examine the relations of serum 25(OH)D and PTH concentrations with insulin sensitivity, independent of adiposity, in healthy women by using a frequently sampled intravenous glucose tolerance test, dualenergy X-ray absorptiometry (DXA), and computed tomography (CT). The use of these robust measures allowed for a thorough investigation of the relations of 25(OH)D and PTH concentrations with whole-body insulin sensitivity, body composition, and fat distribution. Furthermore, this study aimed to determine whether lower 25(OH)D concentrations in AAs contributed to their lower insulin sensitivity.
SUBJECTS AND METHODS

Subjects
Subjects were 50 healthy, premenopausal and postmenopausal women of AA and EA ethnicity identified from 2 studies conducted at the University of Alabama at Birmingham (UAB). Exclusion criteria for both studies were type 1 or type 2 diabetes, polycystic ovary syndrome, disorders of glucose or lipid metabolism, use of medications known to affect body composition or glucose metabolism (including antihypertensive medications), tobacco use, or abnormal glucose tolerance. All premenopausal women had regular menstrual cycles. A portion of the premenopausal women (n = 13) had been previously subjected to a weight-loss intervention (18) and were in the 2-y follow-up phase of the study (2 y after weight loss). Subject selection for this substudy was based on a sufficient quantity of sera to assay 25(OH)D and PTH, as well as available insulin sensitivity, DXA, and CT measurements. The mean age, body mass index (BMI; in kg/m 2 ), percentage body fat, intraabdominal adipose tissue (IAAT), and insulin sensitivity index (S I ) of this substudy did not significantly differ from the respective parent studies, with mean differences ,10% of mean values from the parent studies. All subjects were recruited between February 2001 and February 2007. Both studies were approved by the UAB Institutional Review Board for Human Use, and written informed consent was obtained from all subjects before testing.
Protocol
The protocol for each study was previously reported (18) (19) (20) . In brief, subjects were admitted as in patients to the UAB General Clinical Research Center, and insulin sensitivity and bodycomposition testing was performed. Weight stability in the postweight-loss women was ascertained before testing via a 4-wk weight-maintenance diet with weights checked 3 times/wk and food provided in the last 2 wk. Testing in all premenopausal women was conducted during the follicular phase of the menstrual cycle. Metabolic tests were conducted year round.
Insulin sensitivity testing
Insulin sensitivity was measured by using an insulin-modified intravenous glucose tolerance test and minimal modeling after a 12-h overnight fast, the details of which were previously described (19, 20) . In brief, a catheter was placed in the antecubital space of both arms, and fasted blood samples were drawn for subsequent analyses of lipids and hormones. Glucose (50% dextrose) was injected intravenously at time zero, and multiple subsequent blood draws were taken over a period of 3-4 h. Insulin (0.02 U insulin/kg) was administered at time 20 relative to glucose administration. Samples were processed and stored at 280°C until ready for analysis. S I was determined from insulin and glucose values entered into the MINMOD computer program (version 3; Richard N Bergman, University of Southern California, Los Angeles, CA) (15) . This index has been validated against and correlates well with the gold-standard euglycemic clamp (21) . HOMA-IR was calculated as follows: (11) . Serum PTH concentrations were assessed by a 2-site immunochemiluminometric assay that detected intact PTH and the aminoterminally truncated PTH fragments, and serum calcium concentrations were determined by using spectrophotometry (Quest Diagnostics Nichols Institute). The PTH value for one subject was .3 SD above the mean and, therefore, was excluded from the analyses.
Body composition and fat distribution
Percentage body fat was determined by using DXA (Lunar Prodigy densitometer; GE Healthcare Lunar, Madison, WI) in the UAB Department of Nutrition Sciences. Subjects were scanned in light clothing and in the supine position with their arms to the sides. IAAT and subcutaneous abdominal adipose tissue were determined by using CT (23) with a HiLight/ Advantage Scanner (General Electric, Milwaukee, WI) in the UAB Department of Radiology. Subjects were scanned in the supine position with their arms above their heads. A 5-mm scan was taken at the level of the umbilicus (approximately the L4-L5 intervertebral space) and later analyzed for the crosssectional area (in cm 2 ) of adipose tissue with a density-contour computer program (NIH Image; NIH, Bethesda, MD; http://rsb. info.nih.gov/nih-image/) with Hounsfield units for adipose tissue set at 2190 to 230.
VITAMIN D, PTH, AND INSULIN SENSITIVITY
Statistical analyses
Descriptive characteristics are reported as means (6SDs). The distribution of all continuous variables was examined, and variables that deviated from a normal distribution were log 10 transformed (fasting insulin concentrations, S I , 25(OH)D concentrations, IAAT, and HOMA-IR). Partial correlation analyses, with adjustment for ethnicity, were used to investigate the relations of 25(OH)D and PTH concentrations with indexes of insulin sensitivity. Potential interactions of ethnic group with 25(OH)D and PTH concentrations were investigated with multiple linear regression analysis (MLR). Interaction terms were not statistically significant for any indexes of insulin sensitivity (P . 0.18 for all); thus, data are reported with both ethnic groups pooled together. Forward stepwise MLR was used to explore the best independent predictors of the dependent variable S I . The following variables were tested as predictors of S I : race, IAAT, subcutaneous abdominal adipose tissue, age, percentage body fat, and serum concentrations of PTH, 25(OH)D, and calcium. A significance probability value of 0.15 was used as the criteria for entry into and exit out of the model. Variables observed to be significant in the stepwise analysis were subsequently used in the MLR analysis for S I . To explore the possibility of a threshold effect of vitamin D concentration on S I , MLR analyses were repeated in subjects characterized as vitamin D insufficient. Ethnic differences in continuous variables were determined with 2-group t tests. Ethnic differences in mean S I , adjusted for IAAT and percentage body fat, were determined with analyses of covariance and compared with means that were further adjusted for 25(OH)D and PTH concentrations. Statistical analyses were 2-tailed with a significance level of 0.05 and were performed with SAS software (version 9.1; SAS Institute, Cary, NC).
RESULTS
Descriptive and metabolic characteristics for all women and by ethnic group are presented in Table 1 . A majority of the women were premenopausal (78%) and overweight or obese (53% of women with a BMI .25). Ages ranged from 18.9 to 67.4 y. The mean 25(OH)D concentration was 22.3 6 13.7 ng/mL with 54% of women classified as vitamin D deficient, and 72% of women were classified as vitamin D insufficient. Two-group t tests indicated that AAs had lower 25(OH)D (P , 0.001) concentrations and S I (P , 0.001) than EAs and had greater fasting insulin (P = 0.001) concentrations, HOMA-IR (P = 0.005), and PTH concentrations (P = 0.07). 25 Figure 1 . Subset MLR analysis in subjects with vitamin D insufficiency only is provided in Table 2B . Ethnic group was removed from the reduced model because the majority of subjects were AAs (n = 21), and race was not a significant correlate.
The ethnic difference in S I , which was adjusted for IAAT and percentage fat, was 2. /(lIU/mL)] for EAs and AAs, respectively; P for ethnic difference = 0.008).
DISCUSSION
This study aimed to investigate the relations of circulating 25(OH)D and PTH concentrations with insulin sensitivity by using direct measures of insulin sensitivity after accounting for robust measures of body composition and fat distribution. Results indicated that both 25(OH)D and PTH concentrations were independently associated with a measure of whole-body insulin sensitivity. In addition, the magnitude of lower insulin sensitivity in AAs was reduced by adjustment for 25(OH)D and PTH concentrations. These observations suggest that vitamin D and PTH may play independent roles in the regulation of metabolic health, and that vitamin D supplementation may be useful for minimizing ethnic disparities at risk of type 2 diabetes.
Several studies have shown 25(OH)D concentrations to be associated with insulin sensitivity and resistance (1); however, the majority of studies relied on proxy indexes of insulin sensitivity, used crude measures of adiposity as adjusting variables, and/or have not accounted for PTH. We show, for the first time to our knowledge, that 25(OH)D concentrations were positively associated with a robust measure of insulin sensitivity, independent of percentage body fat, IAAT, and PTH concentrations in a sample of AA and EA women. Our use of DXA-derived percentage body fat and CT-derived IAAT as covariates, as opposed to BMI, provided accurate adjustment for both body composition and abdominal fat accumulation. Nevertheless, our results are in accordance with studies by Lind et al (6) and Chiu et al (3) who showed that 25(OH)D concentrations were positively associated with clamp-derived measures of insulin sensitivity, independent of BMI, in middle-aged Swedish men and in relatively young men and women of varying ethnicity, respectively. However, this is in contrast to a recent study in middle-aged Italian men and women that reported that 25(OH)D concentrations were associated with euglycemic clamp-derived insulin sensitivity but not after adjustment for BMI (24) . It is likely that differences in study populations lead to varying outcomes. The relation between 25(OH)D concentrations and S I was strengthened when only vitamin D insufficient subjects were analyzed (Table 2B) . A comparison of the partial contribution of 25(OH)D to S I in the whole group compared with the vitamin D insufficient subset (9% compared with 48%) suggested that 25(OH)D may be more clinically relevant to insulin sensitivity in vitamin D-insufficient subjects.
In contrast to observations with whole-body insulin sensitivity, 25(OH)D were not significantly associated with HOMA-IR, which is a surrogate measure that primarily reflects hepatic insulin resistance (14) . The minimal model-derived S I encompasses peripheral and hepatic insulin sensitivity (15) . In vitro studies have shown a direct effect of vitamin D concentrations on the up-regulation of human insulin-receptor gene expression and subsequent enhancement of insulin-mediated glucose transport (25, 26) , as well as the promotion of insulin-mediated glucose uptake secondary to increased tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) in muscle cells (C2C12) subjected to free fatty acid-induced insulin resistance (27) . In addition, vitamin D 3 supplementation in Asian-Indian men improved an index of insulin sensitivity derived from an oral glucose tolerance test but did not improve HOMA-IR (28) . Taken together, these findings suggest that vitamin D is more related to insulin-stimulated peripheral glucose uptake as opposed to insulin-mediated inhibition of hepatic glucose production, although glucose tracer studies are required to confirm this hypothesis.
In this study, we observed an association between PTH concentrations and S I , independent of 25(OH)D and adiposity. Several lines of evidence support a direct role of PTH in impeding insulin sensitivity. For example, compared with control subjects, patients with primary hyperparathyroidism are insulin resistant, and insulin sensitivity improves after parathyroidectomy in these patients (29) . In rat adipocytes, insulin-stimulated glucose uptake declined secondary to a PTH-induced elevation in intracellular calcium both in vivo and in vitro (30) . In addition, PTH promoted serine phosphorylation of insulin receptor substrate-1 in 3T3-L1 adipocytes, which resulted in reduced insulin-stimulated glucose uptake (31) . As with 25(OH)D concentrations, we did not find PTH concentrations to be related to HOMA-IR. Few clinical studies examined the relation of PTH concentrations with insulin sensitivity and took into account the potential confounding effects of 25(OH)D concentrations and/or adiposity (4, 12, 13, 24) or considered the relations of PTH concentrations with hepatic compared with peripheral insulin sensitivity. Therefore, to our knowledge, we present novel clinical findings that suggested that PTH concentrations are related to whole-body insulin sensitivity, independent of 25(OH)D and adiposity, and may specifically influence insulin-stimulated glucose uptake.
Although vitamin D deficiency is often accompanied by compensatory increases in serum PTH concentrations (32) (34) (35) (36) . Vitamin D supplementation is a feasible, safe, and relatively inexpensive approach to elevate 25(OH)D concentrations and reduce PTH concentrations in AAs (37) . We previously showed that dietary vitamin D and calcium were positively associated with insulin sensitivity in AA women (38) . Vitamin D and calcium interventions in AAs may thus help to reduce ethnic health disparities in insulin resistance and type 2 diabetes.
Major strengths of this study were the use of sophisticated, robust methodology to measure insulin sensitivity, fat distribution, and body composition. The predictors of S I identified in this study [25(OH)D and PTH concentrations, IAAT, age, and ethnicity] explained 60% of the variance in S I . In addition, measurement of both 25(OH)D and PTH concentrations provided some insight into the independent roles of these hormones on metabolic health. Limitations of the study were that we did not have measures of dietary intake or physical activity in a majority of the women and, thus, could not determine the influence of these factors, and the cross-sectional nature of this study limited our ability to infer cause-and-effect relations. Furthermore, the relatively small sample size in the current study may have limited our power to detect significant ethnic differences in the relations of 25(OH)D and PTH concentrations with metabolic outcomes. Given previous suggestions that relations of dietary vitamin D and 25(OH)D concentrations with metabolic variables may differ in ethnic groups (38, 39) , further study by using an appropriate methodology and sufficient sample size is warranted. 24 Á min 21 /(lIU/mL)] (a 33% decrease) with adjustment for 25(OH)D and PTH. ANCOVA was used to determine adjusted means.
In conclusion, circulating 25(OH)D and PTH concentrations were independently associated with whole-body insulin sensitivity and may be more closely related to peripheral rather than hepatic insulin sensitivity. Although vitamin D and PTH are closely connected in the regulation of skeletal health, they likely influence metabolic health through independent mechanisms. Furthermore, lower 25(OH)D and greater PTH concentrations in AAs compared with EAs may contribute to the ethnic disparities in insulin resistance and type 2 diabetes.
